Yahoo · Oct 31, 2026
Colgate-Palmolive: 3 Key Takeaways for Long-Term Investors
Cost-cutting programs and pricing discipline are shielding margins from commodity inflation, a structural advantage for long-term compounding.

NYSE · CL
Consumer Defensive · Household & Personal Products
$98.76
Up+$3.14 (+3.28%)
Updated Nov 5, 2026, 5:33 AM
SID Score
7.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CL
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
CL closed at $98.76 after 21 trading sessions, up 13.24% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $97.04 | $99.69 | $96.845 | $98.76 | 5.72M |
| Nov 3, 2026 | $96.76 | $96.90 | $95.25 | $95.62 | 5.32M |
| Nov 2, 2026 | $96.305 | $97.76 | $95.87 | $97.43 | 5.08M |
| Oct 30, 2026 | $98.00 | $98.375 | $94.82 | $95.29 | 8.84M |
| Oct 29, 2026 | $93.16 | $93.27 | $91.71 | $93.16 | 4.77M |
| Oct 28, 2026 | $91.05 | $92.16 | $90.47 | $91.69 | 4.65M |
| Oct 27, 2026 | $92.27 | $92.75 | $91.89 | $92.17 | 3.81M |
| Oct 26, 2026 | $93.62 | $94.2823 | $92.49 | $93.10 | 5.51M |
| Oct 23, 2026 | $96.93 | $97.28 | $93.6832 | $94.04 | 4.74M |
| Oct 22, 2026 | $94.56 | $97.50 | $94.5524 | $97.39 | 4.81M |
| Oct 21, 2026 | $93.99 | $94.35 | $93.195 | $93.40 | 4.39M |
| Oct 20, 2026 | $93.50 | $94.56 | $93.21 | $94.54 | 3.64M |
| Oct 19, 2026 | $93.04 | $93.73 | $92.86 | $93.39 | 3.48M |
| Oct 16, 2026 | $93.50 | $94.12 | $92.9343 | $94.11 | 5.78M |
| Oct 15, 2026 | $94.26 | $95.33 | $92.12 | $92.67 | 8.17M |
| Oct 14, 2026 | $90.63 | $92.87 | $90.63 | $92.78 | 5.39M |
| Oct 13, 2026 | $90.92 | $91.0495 | $89.38 | $89.95 | 3.49M |
| Oct 12, 2026 | $88.34 | $89.98 | $88.25 | $89.98 | 4.57M |
| Oct 9, 2026 | $87.67 | $88.66 | $87.64 | $88.27 | 3.17M |
| Oct 8, 2026 | $87.28 | $88.38 | $87.09 | $88.10 | 4.08M |
| Oct 7, 2026 | $87.65 | $88.0484 | $87.20 | $87.21 | 3.77M |
The latest Smart Investors Daily articles mentioning CL.
Company
Market Activity
Research & News
CL research
Company profile and research snapshot.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 3, 2026 | Barclays | Equal-Weight | — |
| Nov 2, 2026 | RBC Capital | Outperform | — |
| Nov 2, 2026 | JP Morgan | Overweight | — |
| Nov 2, 2026 | TD Cowen | Hold | — |
| Nov 2, 2026 | BNP Paribas | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 31, 2026
Cost-cutting programs and pricing discipline are shielding margins from commodity inflation, a structural advantage for long-term compounding.
SeekingAlpha · Oct 31, 2026
Colgate-Palmolive now guides full-year 2026 organic sales growth to be broadly in line with the first three quarters. Read why CL stock is a hold.
Yahoo · Oct 31, 2026
Investing.com -- Oil prices ended October at six-month highs as attacks on shipping in the Strait of Hormuz intensified, complicating diplomatic efforts to end the U.S.-Israel war with Iran.
Yahoo · Oct 30, 2026
Moby summary of Colgate-Palmolive Company's Q3 2026 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CL.